US Stock MarketDetailed Quotes

APRE Aprea Therapeutics

Watchlist
  • 3.050
  • -0.180-5.57%
Close Dec 20 16:00 ET
  • 3.050
  • 0.0000.00%
Post 20:01 ET
16.58MMarket Cap-1.09P/E (TTM)

Aprea Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.10%-2.47M
-13.20%-3.64M
-32.12%-3.94M
51.31%-12.18M
6.99%-3.74M
65.99%-2.24M
63.87%-3.22M
45.79%-2.98M
33.63%-25.01M
60.50%-4.02M
Net income from continuing operations
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
Operating gains losses
1,132.43%35.49K
109.76%5.5K
-507.16%-56.18K
113.83%38.93K
133.99%78.61K
111.83%2.88K
63.53%-56.36K
110.13%13.8K
11.30%-281.53K
147.88%33.6K
Depreciation and amortization
279.12%5.43K
2,267.86%5.3K
1,401.71%6.16K
-96.22%7.05K
309.06%4.99K
-97.67%1.43K
-99.65%224
-99.36%410
-31.37%186.45K
-103.61%-2.39K
Other non cash items
----
----
----
----
----
----
----
----
--72.52M
--0
Change In working capital
27.57%1.13M
-81.80%-310.86K
-184.77%-1.16M
192.05%1.62M
72.23%-462.86K
133.38%882.21K
-108.06%-170.99K
218.87%1.37M
78.88%-1.76M
63.04%-1.67M
-Change in prepaid assets
-6.76%621.83K
-760.13%-436.94K
-37.91%213.64K
-79.36%451.99K
35.98%-625.14K
-35.85%666.89K
-93.46%66.19K
-69.15%344.06K
2,103.04%2.19M
64.59%-976.42K
-Change in payables and accrued expense
157.47%554.37K
194.33%223.74K
-196.92%-994.68K
116.95%637.74K
46.59%-366.69K
105.97%215.32K
-120.49%-237.18K
264.10%1.03M
52.67%-3.76M
59.37%-686.5K
-Change in other current liabilities
----
----
----
--0
----
----
----
----
30.52%-186.7K
93.66%-4.01K
-Change in other working capital
---50.74K
---97.67K
---380.57K
--528.97K
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-10.10%-2.47M
-13.20%-3.64M
-32.12%-3.94M
51.31%-12.18M
6.99%-3.74M
65.99%-2.24M
63.87%-3.22M
45.79%-2.98M
33.63%-25.01M
60.50%-4.02M
Investing cash flow
Cash flow from continuing investing activities
0
-7.5K
-7.98K
-93.09K
-7.15K
-85.94K
0
0
0
0
Net PPE purchase and sale
--0
---7.5K
---7.98K
---93.09K
---7.15K
---85.94K
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
---7.5K
---7.98K
---93.09K
---7.15K
---85.94K
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-1.16K
-21.06K
186.18%14.71M
652.59%5.14M
0
0
0
5.14M
-60.91%682.97K
-94.06%98.53K
Net common stock issuance
--0
--0
176.38%16M
747.61%5.79M
--0
--0
--0
--5.79M
-55.61%682.97K
-93.60%98.53K
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
--0
----
Net other financing activities
---1.16K
---21.06K
-98.77%-1.29M
---648.93K
--0
--0
--0
---648.93K
----
----
Cash from discontinued financing activities
Financing cash flow
---1.16K
---21.06K
186.18%14.71M
652.59%5.14M
--0
--0
--0
--5.14M
-60.91%682.97K
-94.06%98.53K
Net cash flow
Beginning cash position
3.65%28.74M
4.57%32.41M
-24.80%21.65M
-45.76%28.79M
-23.31%25.39M
-29.02%27.73M
-34.95%31M
-45.76%28.79M
-40.38%53.08M
-46.10%33.11M
Current changes in cash
-6.08%-2.47M
-14.09%-3.67M
398.21%10.77M
70.69%-7.13M
4.47%-3.75M
61.25%-2.33M
63.87%-3.22M
139.32%2.16M
32.31%-24.33M
53.96%-3.92M
Effect of exchange rate changes
816.80%24.67K
90.98%-4.82K
-105.01%-2.41K
-121.67%-8.4K
100.09%383
-105.89%-3.44K
-117.08%-53.5K
-32.22%48.16K
1,671.06%38.76K
-342.78%-403.97K
End cash Position
3.53%26.29M
3.65%28.74M
4.57%32.41M
-24.80%21.65M
-24.80%21.65M
-23.31%25.39M
-29.02%27.73M
-34.95%31M
-45.76%28.79M
-45.76%28.79M
Free cash flow
-6.03%-2.47M
-13.44%-3.65M
-32.39%-3.94M
50.94%-12.27M
6.81%-3.75M
64.69%-2.33M
63.87%-3.22M
45.79%-2.98M
33.63%-25.01M
60.50%-4.02M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.10%-2.47M-13.20%-3.64M-32.12%-3.94M51.31%-12.18M6.99%-3.74M65.99%-2.24M63.87%-3.22M45.79%-2.98M33.63%-25.01M60.50%-4.02M
Net income from continuing operations -18.08%-3.78M-6.47%-3.47M35.84%-2.81M87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M
Operating gains losses 1,132.43%35.49K109.76%5.5K-507.16%-56.18K113.83%38.93K133.99%78.61K111.83%2.88K63.53%-56.36K110.13%13.8K11.30%-281.53K147.88%33.6K
Depreciation and amortization 279.12%5.43K2,267.86%5.3K1,401.71%6.16K-96.22%7.05K309.06%4.99K-97.67%1.43K-99.65%224-99.36%410-31.37%186.45K-103.61%-2.39K
Other non cash items ----------------------------------72.52M--0
Change In working capital 27.57%1.13M-81.80%-310.86K-184.77%-1.16M192.05%1.62M72.23%-462.86K133.38%882.21K-108.06%-170.99K218.87%1.37M78.88%-1.76M63.04%-1.67M
-Change in prepaid assets -6.76%621.83K-760.13%-436.94K-37.91%213.64K-79.36%451.99K35.98%-625.14K-35.85%666.89K-93.46%66.19K-69.15%344.06K2,103.04%2.19M64.59%-976.42K
-Change in payables and accrued expense 157.47%554.37K194.33%223.74K-196.92%-994.68K116.95%637.74K46.59%-366.69K105.97%215.32K-120.49%-237.18K264.10%1.03M52.67%-3.76M59.37%-686.5K
-Change in other current liabilities --------------0----------------30.52%-186.7K93.66%-4.01K
-Change in other working capital ---50.74K---97.67K---380.57K--528.97K------------------------
Cash from discontinued investing activities
Operating cash flow -10.10%-2.47M-13.20%-3.64M-32.12%-3.94M51.31%-12.18M6.99%-3.74M65.99%-2.24M63.87%-3.22M45.79%-2.98M33.63%-25.01M60.50%-4.02M
Investing cash flow
Cash flow from continuing investing activities 0-7.5K-7.98K-93.09K-7.15K-85.94K0000
Net PPE purchase and sale --0---7.5K---7.98K---93.09K---7.15K---85.94K--0--0--0--0
Cash from discontinued investing activities
Investing cash flow --0---7.5K---7.98K---93.09K---7.15K---85.94K--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities -1.16K-21.06K186.18%14.71M652.59%5.14M0005.14M-60.91%682.97K-94.06%98.53K
Net common stock issuance --0--0176.38%16M747.61%5.79M--0--0--0--5.79M-55.61%682.97K-93.60%98.53K
Proceeds from stock option exercised by employees --------------0------------------0----
Net other financing activities ---1.16K---21.06K-98.77%-1.29M---648.93K--0--0--0---648.93K--------
Cash from discontinued financing activities
Financing cash flow ---1.16K---21.06K186.18%14.71M652.59%5.14M--0--0--0--5.14M-60.91%682.97K-94.06%98.53K
Net cash flow
Beginning cash position 3.65%28.74M4.57%32.41M-24.80%21.65M-45.76%28.79M-23.31%25.39M-29.02%27.73M-34.95%31M-45.76%28.79M-40.38%53.08M-46.10%33.11M
Current changes in cash -6.08%-2.47M-14.09%-3.67M398.21%10.77M70.69%-7.13M4.47%-3.75M61.25%-2.33M63.87%-3.22M139.32%2.16M32.31%-24.33M53.96%-3.92M
Effect of exchange rate changes 816.80%24.67K90.98%-4.82K-105.01%-2.41K-121.67%-8.4K100.09%383-105.89%-3.44K-117.08%-53.5K-32.22%48.16K1,671.06%38.76K-342.78%-403.97K
End cash Position 3.53%26.29M3.65%28.74M4.57%32.41M-24.80%21.65M-24.80%21.65M-23.31%25.39M-29.02%27.73M-34.95%31M-45.76%28.79M-45.76%28.79M
Free cash flow -6.03%-2.47M-13.44%-3.65M-32.39%-3.94M50.94%-12.27M6.81%-3.75M64.69%-2.33M63.87%-3.22M45.79%-2.98M33.63%-25.01M60.50%-4.02M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data